Literature DB >> 23561280

Canadians' support for radical life extension resulting from advances in regenerative medicine.

Nick Dragojlovic1.   

Abstract

This paper explores Canadian public perceptions of a hypothetical scenario in which a radical increase in life expectancy results from advances in regenerative medicine. A national sample of 1231 adults completed an online questionnaire on stem cell research and regenerative medicine, including three items relating to the possibility of Canadians' average life expectancy increasing to 120 years by 2050. Overall, Canadians are strongly supportive of the prospect of extended lifespans, with 59% of the sample indicating a desire to live to 120 if scientific advances made it possible, and 47% of respondents agreeing that such increases in life expectancy are possible by 2050. The strongest predictors of support for radical life extension are individuals' general orientation towards science and technology and their evaluation of its plausibility. These results contrast with previous research, which has suggested public ambivalence for biomedical life extension, and point to the need for more research in this area. They suggest, moreover, that efforts to increase public awareness about anti-aging research are likely to increase support for the life-extending consequences of that research program.
Copyright © 2013 Elsevier Inc. All rights reserved.

Mesh:

Year:  2013        PMID: 23561280     DOI: 10.1016/j.jaging.2012.12.008

Source DB:  PubMed          Journal:  J Aging Stud        ISSN: 0890-4065


  2 in total

1.  Slowing Down Time: An Exploration of Personal Life Extension Desirability as it Relates to Religiosity and Specific Religious Beliefs.

Authors:  Scott Ballinger; Theresa Clement Tisdale; David L Sellen; Loren A Martin
Journal:  J Relig Health       Date:  2017-02

2.  Great Desire for Extended Life and Health amongst the American Public.

Authors:  Yoni Donner; Kristen Fortney; Stuart R G Calimport; Karl Pfleger; Munjal Shah; Joe Betts-LaCroix
Journal:  Front Genet       Date:  2016-01-20       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.